Undiscovered Gems in the US Market to Watch This January 2025

The United States market has shown robust performance, rising 3.2% in the last week and climbing 24% over the past year, with all sectors experiencing gains. In this thriving environment, a good stock often combines strong growth potential with solid fundamentals, making it an attractive option for investors seeking to capitalize on current market momentum.

Top 10 Undiscovered Gems With Strong Fundamentals In The United States

Name	Debt To Equity	Revenue Growth	Earnings Growth	Health Rating
Eagle Financial Services	170.75%	12.30%	1.92%	★★★★★★
Morris State Bancshares	10.20%	-0.28%	6.97%	★★★★★★
Wilson Bank Holding	NA	7.87%	8.22%	★★★★★★
Omega Flex	NA	0.39%	2.57%	★★★★★★
First Northern Community Bancorp	NA	7.65%	11.17%	★★★★★★
Teekay	NA	-3.71%	60.91%	★★★★★★
Parker Drilling	46.05%	0.86%	52.25%	★★★★★★
ASA Gold and Precious Metals	NA	7.11%	-35.88%	★★★★★☆
FRMO	0.08%	38.78%	45.85%	★★★★★☆
Pure Cycle	5.15%	-2.61%	-6.23%	★★★★★☆

Click here to see the full list of 253 stocks from our US Undiscovered Gems With Strong Fundamentals screener.

Underneath we present a selection of stocks filtered out by our screen.

Andersons (NasdaqGS:ANDE)

Simply Wall St Value Rating: ★★★★★★

Overview: The Andersons, Inc. is a diversified company engaged in the trade, renewables, and nutrient and industrial sectors across various countries including the United States, Canada, Mexico, Egypt, and Switzerland with a market capitalization of approximately $1.50 billion.

Operations: Andersons generates revenue primarily from three segments: trade ($7.61 billion), renewables ($2.88 billion), and nutrient & industrial, including turf & specialty ($852.05 million). The company's market capitalization is approximately $1.50 billion.

Andersons, a promising player in the agribusiness and renewables sectors, has shown robust financial performance with an 84.5% earnings growth over the past year, outpacing industry averages. The company's debt to equity ratio improved significantly from 113.9% to 38.4%, reflecting strong fiscal discipline. Trading at a price-to-earnings ratio of 12.5x, below the US market average of 18.9x, it offers good relative value compared to peers and industry standards. Recent strategic investments like Skyland Grain LLC and Port of Houston are likely to enhance operational efficiencies and expand market reach, positioning Andersons for sustained growth despite potential market challenges.

• Andersons' strategic investments in agribusiness and renewable energy aim to boost earnings through operational efficiencies. Click here to explore the full narrative on Andersons' growth strategy.

Associated Capital Group (NYSE:AC)

Simply Wall St Value Rating: ★★★★★★

Overview: Associated Capital Group, Inc. is a company that, along with its subsidiaries, offers investment advisory services in the United States and has a market capitalization of approximately $768.36 million.

Operations: Associated Capital Group's primary revenue stream is derived from investment advisory and asset management services, generating $13.66 million.

Associated Capital Group, a financial entity with no debt, has showcased impressive earnings growth of 62.2% over the past year, outpacing the Capital Markets industry average of 14.3%. The firm reported net income of US$23 million for Q3 2024 compared to a slight loss in the previous year’s quarter. Its price-to-earnings ratio stands at 13.6x, offering potential value against the broader US market's 18.9x benchmark. Recent activities include repurchasing over 121,000 shares and declaring a semi-annual dividend of US$0.10 per share, indicating robust shareholder returns and strategic capital allocation efforts.

• Delve into the full analysis health report here for a deeper understanding of Associated Capital Group.

• Examine Associated Capital Group's past performance report to understand how it has performed in the past.

National HealthCare (NYSEAM:NHC)

Simply Wall St Value Rating: ★★★★★☆

Overview: National HealthCare Corporation operates skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals with a market capitalization of approximately $1.52 billion.

Operations: National HealthCare Corporation generates revenue primarily from inpatient services amounting to $1.04 billion and homecare and hospice services contributing $137.47 million.

National HealthCare, a smaller player in the healthcare sector, has demonstrated impressive financial performance. Over the past year, its earnings surged by 177.7%, outpacing the industry's growth of 11.8%. Despite a notable one-off gain of US$84.3M affecting recent results, the company maintains a robust cash position exceeding its total debt. However, its debt to equity ratio rose from 3.9% to 14.9% over five years, indicating increased leverage. Trading at 63% below estimated fair value suggests potential undervaluation while it continues to pay dividends with US$0.61 per share announced for early 2025 distribution.

• Click here to discover the nuances of National HealthCare with our detailed analytical health report.

• Learn about National HealthCare's historical performance.

Make It Happen

• Discover the full array of 253 US Undiscovered Gems With Strong Fundamentals right here.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com